GALECTIN THERAPEUTICS INC (GALT) Stock Income Statement
NASDAQ:GALT - Nasdaq - US3632252025 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 40.68M | 42.43M | 38.07M | 38.35M | 30.18M | |||
| Research and Development | 35.00M | 36.57M | 32.13M | 31.74M | 23.82M | |||
| Selling, General, and Administrative Expenses | 5.68M | 5.86M | 5.94M | 6.62M | 6.36M | |||
| Operating Income | -40.68M | -42.43M | -38.07M | -38.35M | -30.18M | |||
| Interest Income/Expense | -4.51M | -4.61M | -2.99M | -420.00K | -350.00K | |||
| Income Before Taxes | -45.19M | -47.05M | -41.07M | -38.78M | -30.53M | |||
| Net Income | -45.31M | -47.20M | -44.80M | -38.87M | -30.70M | |||
| EBITDA | N/A | -42.40M | -38.04M | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.72 | -0.76 | -0.74 | -0.65 | -0.52 | |||
| Non GAAP EPS | -0.72 | -0.76 | -0.74 | -0.65 | -0.51 | |||
| Statistics | ||||||||
All data in USD